Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients (Q46141026)

19 December 2017

title

Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients (English)

1 reference

19 December 2017

1 reference

Xiao-Yun Yang

1

1 reference

19 December 2017

Ming-Rong Xi

series ordinal

2

1 reference

19 December 2017

Kai-Xuan Yang

series ordinal

3

1 reference

19 December 2017

Hai Yu

series ordinal

4

1 reference

19 December 2017

language of work or name

English

0 references

publication date

29 January 2009

1 reference

19 December 2017

published in

Gynecologic Oncology

1 reference

19 December 2017

volume

113

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

99-104

1 reference

19 December 2017

Steroid hormones and cancer: (III) observations from human subjects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Estrogen receptor expression is a common feature of ovarian borderline tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Estrogen and progesterone receptors in ovarian epithelial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Estrogen and progesterone receptors in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Prognostic factors in early-onset epithelial ovarian cancer: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Favorable clinical behavior in young ovarian carcinoma patients: a rationale for conservative surgery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Survival and prognostic factors in patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

BRCA1Mutations in a Population-Based Sample of Young Women with Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.018

10.1016/J.YGYNO.2008.12.018

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017